Podcasts about Psoriasis

Dr. Mohammad Ashori is a board-certified family medicine physician, health coach, and rock climber. We talked about the importance of putting on muscle, how much rest we need between training sessions, nutrition and metabolic health, zone 2 cardio, key metrics and blood markers to track, different levels of data, why some data can be misleading or harmful, relative vs. absolute risk, and much more. Want to work with Dr. Ashori? Get 15% off your 1st health assessment with Dr. Ashori. Book your schedule here and use the code: NUGGET15 Want climbing or nutrition coaching? Free Masterclass (Learn more about Climb Accelerator)

The Derm on RheumNow podcast is a review of recent citations and content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, CTD skin disorders. dermatology drugs, biologics, andJAK inhibitors - their use, efficacy and side effects. Features Dr. Jack Cush, Editor at RheumNow.com. Show Notes: Latest #s: EHR estimates from 6 large US medical systems, estimated prevalence of autoimmune Dz (AID) to be 15 million (4.6% US population); 34% have 2+ AID. Women have 2x risk. Sex ratio of 1.7:1 F:M. https://buff.ly/fYgRfZ0 POETYK PsA-1: Deucravacitinib in Biologic-Naïve PsA POETYK PsA-1 trial tested the disease modifying efficacy of deucravacitinib, a tyrosine kinase 2 (TYK2) inhibitor, in PsA patients and was shown to be superior vs to placebo for clinical responses, patient-reported outcomes, https://t.co/VjwpCVKPz0 MoonLake announced positive phase 3 data from its IZAR-1 RCT using its dual A/F IL-17 inhibitor sonelokimab, showing significant responses at week 16: 66% ACR20, 42% ACR50, 41% minimal disease activity (MDA), & 61% PASI90 at week 16. a 2nd IZAR-2 PsA RCT is in progress https://t.co/eX0cxekRKG British Dermatology Biologics registry (BADBIR) 18976 #PSO pts had incidence serious infxns (SIE) 28 SEI/1000 Pt-Yrs; higher if they had prior infxn (79/1000 PYs). SIE signif lower w/ RIZankizumab (HR 0.74-.80) vs BROAD, ETN, other standards Rxs. SIE deaths rare (1.81/1000 PYs) https://t.co/GTr3DLCVXs 39 studies compared Juvenile systemic sclerosis (jSSc) & adult SSc. 935 jSSc vs 15,451 aSSc pts; jSSc had more diffuse cutaneous dz (70% vs 41%), more overlap myositis (33% vs. 5%), arthritis (33% vs 18%), digital ulcers (51% vs 20%), less renal crisis (0% vs 6%) & lower mortality jSSc (7.7% vs. 20.4%) https://t.co/vflarmwSyv Italian SPRING cohort of #SSc pts found only 5.3% (of 1689 pts) without the typical scleroderma pattern on nailfold change by NVC. They had milder dz, with less vascular dz (pitting scars 33 vs 48%), telangiectasias (52 vs 74%), calcinosis 3.4 vs 12%) & higher DLCOs at 12, 24, https://t.co/AoNAhVYfII Review of CAR-T 29 trials in systemic sclerosis (SSc): 27/29 target CD19 (other CD20, BCMA), 20/29 autologous. Only 2 RCTs; 1 w/ RTX comparator. Most included CREST. Schetts largest series had 6 dcSSc w/ skin/lung improvements. Need fewer & larger multicenter RCTs https://t.co/Me28HbaFhR SLE & Dermatomyositis rashes maybe classically red or violaceous in Whites,but different in people of color, where erythema often appears brown/violaceous, Gottron papules can be mistaken for "dry skin." This delays dx, especially in anti-MDA5+ RP-ILD, where rash may be the https://t.co/Savx5IOTcG Yesterday the EMA approved upadacitinib (Rinvoq) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo - the 1st therapy approved for the most common form of vitiligo. Based on positive results from the Phase 3 Viti-Up trials https://t.co/MMv5LjZclQ 3 Rx are FDA approved for hidradenitis supprativa (secukinumab, adalimumab, bimekizumab). New JAK1i Povorcitinib in STOP-HS1 and STOP-HS2 ph 3 PCTs (608/619 pts). Povo showed HiSCR50 ~42% vs PBO 29% @wk12. AE: acne, pharyngitis https://t.co/n3FJUOjNuo

If your face has gotten redder, more reactive and burning in your in your 40s or 50s (or your rosacea seems much worse), perimenopause rosacea could be an important piece of the puzzle. Emerging research suggests shifting hormone levels can trigger and also influence rosacea symptoms, including acne bumps, reactive skin, flushing, burning, stinging + increased skin sensitivity.Before you JUST blame this all on hormones, hormone-triggered rosacea must be looked at from a few different perspectives. In this episode, I'm diving into fascinating research connecting hormones, your gut microbiome + rosacea severity, plus what to consider when the usual rosacea fixes aren't giving you sustainable results.⭐️Mentioned in This Episode:- See all the references

In this episode of PeDRA Pearls, Jenn Dawson talks with Tina Ho, MD, PhD, and Joy Wan, MD, about the Atopic Dermatitis and Psoriasis Focused Study Group and its collaborative efforts to advance pediatric dermatology research. They explore the impact of eczema on children and families, the importance of patient-reported outcomes and treatment access, and how bringing researchers together through PeDRA can turn ideas into meaningful research.This episode is presented by Disc Medicine. Although Disc Medicine provided funding for this PeDRA Pearls Podcast, the contents of the podcast were developed independently by PeDRA. Learn more about Disc Medicine.

Episode 379 | Skin on Fire—Healing Psoriasis from the Inside OutWe welcome back chiropractor and author Anik St. Martin to discuss her new book, Skin on Fire: Healing Psoriasis Naturally. Drawing from her own decades-long experience with psoriasis, Dr. Anik makes the case that psoriasis is not simply a skin condition but rather an autoimmune problem that requires looking beneath the symptoms. We cover genetics and epigenetics, physical, chemical and emotional stress, immune disruption, inflammation, gut dysbiosis and toxicity, along with her experiences with steroids, methotrexate, biologics and vaccine products. She also walks us through the natural healing approach and 90-day drug-free program she developed using diet, supplementation, detoxification, mindset and nervous-system restoration. Dr. Anik practices chiropractic in Longview and Battle Ground, and she delivered the keynote speech at ICWA's Health Freedom Day in Olympia earlier this year.Book: Skin on Fire: Healing Psoriasis Naturally - https://amzn.to/4wRsfnFPractice: Advantage Chiropractic - https://myadvantagechiro.com/When you get Dr. Anik's book at the foregoing Amazon link, ICWA will receive a small commission at no extra cost to you.For your other Amazon purchases, you can support our work by always starting your shopping from the link on our homepage - https://www.informedchoicewa.org/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Caitriona Ryan, Clinical Professor at UCD and Consultant Dermatologist

Bone loss can happen silently for years, which is why osteoporosis isn't often discovered until you break a bone. In this episode, we explore why osteoporosis isn't simply an inevitable part of aging, plus the medications, nutrition, exercise, inflammation, and gut-bone connection that may influence your fracture risk.We'll also unpack some surprising problems with DEXA scans, including why improving your bone density score doesn't always mean your fracture risk has improved. You'll learn what else matters for building stronger bones and why protecting bone health should start long before an osteoporosis diagnosis.My guest is Dr. John Neustadt, ND, an integrative and functional medicine expert and bestselling author of Fracture-Proof Your Bones. He has published more than 100 medical articles and is internationally recognized for his work on osteoporosis and fracture prevention.⭐️Mentioned in This Episode:- See all the references

Kim Kardashian joins Mary Alice Haney and Dr. Thais Aliabadi on SHE MD for an honest conversation about living with psoriasis and psoriatic arthritis. Kim opens up about her first flare, the challenges of managing psoriasis in the public eye, the treatments and lifestyle changes she's tried, and what finally helped get her symptoms under control. Alongside Dr. Wallace, Mary Alice and Dr. Thais break down what psoriasis actually is, how it can affect the joints and other parts of the body, how it's diagnosed, and when it's time to see a dermatologist or rheumatologist. They also discuss genetics, stress, self-care, and why understanding what's happening beneath the skin is so important.Kim also shares why she's chosen to be open about her health and use her platform to bring more awareness to psoriasis and help others feel less alone.Subscribe to SHE MD Podcast for expert tips on PMOS, endometriosis, fertility, hormonal balance, mental health, and more. Share with friends and visit SHE MD website and Ovii for research-backed resources, holistic health strategies, and expert guidance on women's health and well-being.SponsorsSmile Set:  Listeners of our show get an additional 35% off discount when they go to smileset.com/shemd. With this discount, you can get the smile of your dreams for under 1,300 bucks. Ladder:  If you have an iPhone, head to ladder.fit/shemd. Take the quick quiz and find your plan. You'll get a free seven-day trial, no credit card required, and $10 off your first month when you join.BEAM Minerals: Get 20% off your first order at beamminerals.com/shemd with code SheMD.Gusto:  Try Gusto today at gusto.com/shemd and get three months free when you run your first payroll. Acely:  If your student is heading into testing season and you wanna help them achieve a life-changing score, go to acey.com and use code SheMD for 20% off today.Skylight Frames:  Go to myskylight.com/shemd for $30 off your 15-inch calendar. What You'll LearnWhat psoriasis is and how it affects the skinWhy psoriasis is considered an immune-mediated conditionThe different types of psoriasis and how they can presentHow psoriasis can be connected to psoriatic arthritisWhy diagnosing psoriasis and psoriatic arthritis can sometimes be complicatedWhen topical treatments may be enough and when systemic therapy may be consideredWhy certain topical steroids need to be used carefullyHow stress and the mind-body connection may relate to psoriasisWhat Kim Kardashian experienced throughout her own psoriasis journeyWhy seeking medical care is important instead of relying solely on social media or home remediesKey Timestamps00:00 Welcome Kim Kardashian & Dr. Daniel J. Wallace02:25 Kim's First Psoriasis Flare at Age 3009:04 What Exactly Is Psoriasis?15:05 When to See a Dermatologist or Rheumatologist22:25 How Doctors Diagnose & Evaluate Psoriasis26:22 Topical Steroids & How to Use Them Safely29:32 Kim's Psoriatic Arthritis & Flare-Up Experience33:45 Kim's Skincare & Self-Care Routine35:45 Kim on Living With Psoriasis in the Public Eye38:13 Kim's Workout, Supplements & Wellness Routine41:04 Kim's Advice to Her Younger Self43:48 5 Things to Know If You Think You Have Psoriasis44:39 Final Thoughts & GoodbyeKey TakeawaysPsoriasis can look different from person to person and may range from localized skin lesions to more extensive disease.Psoriasis can affect more than the skin, including the joints and potentially other parts of the body.Psoriatic arthritis can develop in people with psoriasis and may cause joint pain and swelling.Treatment depends on the type and severity of psoriasis, and some people may require systemic therapy.Strong topical steroids can be effective but need to be used carefully, particularly on the face.Stress, self-care, exercise, and overall lifestyle can be important parts of managing health, although individual triggers and experiences vary.Medical evaluation is important when psoriasis is suspected, especially when joint symptoms are present.Guest Bio: Kim KardashianKim Kardashian is a cultural trailblazer, actress, fashion icon, activist, entrepreneur, and devoted mother of four. She revolutionized the shapewear market with her cult-favorite brand SKIMS and has significantly transformed the beauty industry through her highly successful cosmetic and fragrance lines, KKW Beauty and KKW Fragrance. Beyond her business acumen, Kim is a powerful advocate for criminal justice reform and is currently pursuing a law degree. Her influence on contemporary culture is unparalleled, making her a defining figure of our time.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This Week’s Big Questions! You’ve been sending in your brilliantly curious questions, and this week…

In this 2-part series, Jennifer Winstead shares her incredible story with Sue Becker about how switching to freshly-milled flour helped completely transform her health. After years of struggling with severe IBS, autoimmune challenges, and dental issues following Accutane use, Jennifer discovered the healing power of nourishing her body with Real Bread. Hear how her journey of restoration gave her hope—and ultimately gave her life. Make sure to listen to Part 1 of this series, where Jennifer shares her amazing health story. Topics on this episode: Accutane, dermatology, Irritable Bowel Syndrome (IBS), Fibromyalgia, Lupus, Psoriasis, dental, detox LISTEN NOW and SUBSCRIBE to this podcast here or from any podcasting platform such as, Apple Podcasts, YouTube, Spotify, Alexa, Siri, or anywhere podcasts are played. Follow Jennifer Winstead and hear more of her story

"My allergy tests were normal”. Christa had itchy, painful, burning skin that suddenly appeared overnight. Yet all her testing all came back negative for allergies. With no clear answers, she was left struggling with histamine reactive eczema that hurt even when showering.After getting fired from her doctor for asking too many questions, she began diving into what was really driving her symptoms—she suspected it could be histamine intolerance.In this episode, you'll hear Christa's powerful journey that left her facing many frustrating dead ends, the surprising discoveries that changed everything, and what finally stopped her skin flares for good. If you've been told your tests are normal but know something still isn't right, this conversation will help you understand why negative allergy tests don't always tell the full story and what steps you can take next.⭐️Mentioned in This Episode:- Watch the FREE Fix My Skin Workshop

The Derm on RheumNow podcast is a review of recent citations and content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, CTD skin disorders. dermatology drugs, biologics, andJAK inhibitors - their use, efficacy and side effects. Features Dr. Jack Cush, Editor at RheumNow.com. Show Notes: - 20 yr. Tx trends in 6583 #SSc pts. 2005 to 2025 endothelin receptor antagonists & prostanoids/prostacyclins from 3% to 28%. CCB & PDE-5 inh stable. CTX shifted to mycophenolate, RTX, & nintedanib. Steriods decr from 50% to 18% https://t.co/nrm1Ov285f https://t.co/ftLn3bGH72 Systemic sclerosis metanalysis of 31 studies (32,134 pts) shows malignancy risk signif increased (SIR 1.66; CI 1.32 - 2.08). Highest: esophageal, liver, cervical, lung, & Heme (SIR 3.35 - 13.95). 7.4 yr mean from SSc to CA dx. https://t.co/IhxvfkMqkf RZV (Shingrix) response in 76 immunosuppressed SSc & 304 controls (CG) recv two RZV doses. High seroconversion seen in SSc but signif lower than CG (92.6% vs 99.7%, P 0.001), w/ lower concentration but comparable CMI, lower AE (74% vs 86%) https://t.co/ALlnVEZIAt https://t.co/kYYy2JIo2J Raynauds: Using the Clinical Practice Research Datalink Aurum (PCP) database (1998 - 2023) the prevalence of Raynaud's 894/100 000, or 158449 cases in 2023. More in elderly & females, less in blacks. Incidence rate 46/100K https://buff.ly/TLjMy21 Guidelines to Spot Cancer in High Risk Dermatomyositis Psoriatic Arthritis: EULAR 2026

In this 2-part series, Jennifer Winstead shares her incredible story with Sue Becker about how switching to freshly-milled flour helped completely transform her health. After years of struggling with severe IBS, autoimmune challenges, and dental issues following Accutane use, Jennifer discovered the healing power of nourishing her body with Real Bread. Hear how her journey of restoration gave her hope—and ultimately gave her life. Topics on this episode: Accutane, dermatology, Irritable Bowel Syndrome (IBS), Fibromyalgia, Lupus, Psoriasis, dental, detox LISTEN NOW and SUBSCRIBE to this podcast here or from any podcasting platform such as, Apple Podcasts, YouTube, Spotify, Alexa, Siri, or anywhere podcasts are played. Follow Jennifer Winstead and hear more of her story

I'm talking with Dr. Anik St. Martin, a chiropractor and author of Skin on Fire: Healing Psoriasis Naturally, who spent over 12 years battling psoriasis before discovering the one piece she'd been missing — her mindset. After years of dialing in her nutrition, supplements, and gut healing, Anik's skin finally cleared completely after a self-directed 5-day intensive where she did nothing but walk, observe her thoughts, and flip every self-deprecating thought to its opposite. We get into the science behind why this works — from a 1940s Harvard placebo study to real-time synaptic rewiring — and why the fact that your skin turns over every 21 days is actually great news. We also cover: • The environmental triggers that worsened her psoriasis (vaccines in one sitting, formaldehyde, tattoo ink) • Why obsessing over a "perfect" healing protocol can be just as harmful as the condition itself • Her go-to supplements and GI repair formula for managing flares • The one morning practice she recommends everyone start today If you've tried everything and still aren't where you want to be, this episode is worth your time. For the complete show notes, links and transcripts, visit inspiredliving.show/254

Board-certified dermatologists Dr. Ted Lain and pediatric dermatology expert Dr. Lisa Swanson break down the latest pediatric dermatology treatments in this episode of the Science of Skin Podcast.Topics covered: atopic dermatitis (eczema) treatment updates including Zoryve, Vtama, and Opzelura; pediatric psoriasis therapies including Zoryve foam, Tremfya, and the oral IL-23 inhibitor Sotyktu; GLP-1 medications (Ozempic/semaglutide) for psoriasis and hidradenitis suppurativa; spironolactone dosing for teenage female acne; hemangioma treatment with timolol, propranolol (Hemangiol), and nadolol; molluscum contagiosum treatment with Ycanth and berdazimer gel (Zelsuvmi); and JAK inhibitors (Litfulo, Olumiant, Rinvoq) for pediatric alopecia areata and early intervention strategies.Plus: a lighthearted dive into Bachelor Nation, Secret Lives of Mormon Wives, Love Island, and Taylor Swift's wedding buzz.Send episode topic ideas to questions@scienceofskinsummit.com. Subscribe and leave a 5-star rating to support the show.Join us at the Science of Skin Summit, September 17–20 in Austin, Texas, and the Longevity Conference, February 19–21 in Scottsdale, Arizona. Learn more at scienceofskinsummit.com.Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.

➡️ Shop Eversio Wellness and save 15% with code PODCAST15 ⬅️ https://www.eversiowellness.com/discount/PODCAST15?redirect=%2Fcollections%2Fall-productsThis is Part 1 of our brand-new Skin Series. We're starting with psoriasis because it's personal for both of us. Brandi shares her history with psoriasis starting at age 15, over a decade on a pharmaceutical biologic, and how she eventually found her way to remission through a combination of lifestyle shifts and functional mushrooms. Dr. Desiree breaks down the exact immune mechanism driving psoriasis, including the IL-23/IL-17 pathway, the TH17 cell overactivation loop, and the documented role of oxidative stress as a contributing factor in the disease process. Then we walk through why chaga is the functional mushroom most aligned with this picture, what the research actually shows, and how the gut-skin axis connects it all.

In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes E. James Song, MD, for a discussion of the IL-23 pathway and its enduring role in psoriasis management. Although therapeutic options continue to expand, IL-23 remains a central target because of its key role in the IL-23/Th17 axis, one of the primary drivers of psoriatic disease. Dr Song reviews the current IL-23 therapeutic landscape, comparing available agents that target the pathway through different mechanisms. He highlights important distinctions among therapies, including dosing intervals, molecular characteristics, binding affinity, and immunogenicity, while emphasizing that all have demonstrated strong efficacy and favorable safety profiles. The conversation also explores how these pharmacologic differences do—and do not—translate into meaningful clinical differences. The conversation also explores patient access, with Drs Del Rosso and Song discussing how route of administration and insurance coverage can significantly influence treatment selection, particularly for Medicare beneficiaries. They examine the practical advantages of health care provider-administered therapy, including more reliable treatment delivery, closer patient follow-up, and reduced financial barriers for some patients. The discussion also addresses expectations for treatment response, emphasizing that IL-23 inhibitors may require more time than other biologic classes to achieve maximal benefit. Dr Song shares practical insights into assessing early improvement, counseling slower responders, and supporting long-term treatment persistence. The episode concludes with a review of the safety profile of IL-23 inhibitors, including their role in psoriasis with peripheral psoriatic arthritis, while discussing areas where these therapies remain more limited, such as axial disease and uveitis. Tune in to the full episode to learn more about the IL-23 pathway, the similarities and distinctions among available therapies, practical access considerations, and setting realistic expectations for treatment response in everyday psoriasis care.

Host: Darryl S. Chutka, M.D.  Guest: Dawn Davis, M.D.  Psoriasis is a health condition commonly seen in primary care but one which has evolved significantly in both how we understand the disease as well as how it's managed. At one time, psoriasis was considered primarily a skin disorder; however, we now know it's part of a systemic inflammatory disease with potential involvement of multiple organ systems. What do we know about the pathophysiology of psoriasis? How does it change our management when we think of it as a systemic disease? What are some of the new treatment options we now have available?  I'll ask these questions and more of my guest as we discuss “Psoriasis”.  My guest for this podcast is Dr. Dawn Davis, Chair of Clinical and Pediatric Dermatology at the Mayo Clinic in Rochester, Minnesota.  Connect with us! Mayo Clinic Talks Podcast Season 6 | Mayo Clinic School of Continuous Professional Development 

Board-certified dermatologists Dr. Ted Lain and pediatric dermatology expert Dr. Lisa Swanson break down the latest pediatric dermatology treatments in this episode of the Science of Skin Podcast. Topics covered: atopic dermatitis (eczema) treatment updates including Zoryve, Vtama, and Opzelura; pediatric psoriasis therapies including Zoryve foam, Tremfya, and the oral IL-23 inhibitor Sotyktu; GLP-1 medications (Ozempic/semaglutide) for psoriasis and hidradenitis suppurativa; spironolactone dosing for teenage female acne; hemangioma treatment with timolol, propranolol (Hemangiol), and nadolol; molluscum contagiosum treatment with Ycanth and berdazimer gel (Zelsuvmi); and JAK inhibitors (Litfulo, Olumiant, Rinvoq) for pediatric alopecia areata and early intervention strategies. Plus: a lighthearted dive into Bachelor Nation, Secret Lives of Mormon Wives, Love Island, and Taylor Swift's wedding buzz. Send episode topic ideas to questions@scienceofskinsummit.com. Subscribe and leave a 5-star rating to support the show. Join us at the Science of Skin Summit, September 17–20 in Austin, Texas, and the Longevity Conference, February 19–21 in Scottsdale, Arizona. Learn more at scienceofskinsummit.com. Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.

It's easy to blame yourself when medications like Dupixent, Adbry, or Ebglyss don't work (or work well enough), your doctor says that you've “failed” it and it's time to move on to something else. Very often, no one is asking, "Why wasn't Dupixent able to work in the first place?" which could uncover important clues about your eczema case potentially lurking under the surface.Because YOU didn't fail the drug, and before moving on to something else, this is what you absolutely need to consider.Plus, we'll talk about a little-known warning in the safety information for Dupixent and other IL-13-blocking biologics specifically about parasites. So let's dive into what I've seen in clients prescribed these medications and why what looks like drug failure to their doctor could be an important root cause clue.⭐️Mentioned in This Episode:- See all the references

Dealing with the heat - Europeans' disdain for air conditioningI have scaly and bumpy areas on my scalp that itch!Did homeopathic human growth hormone increase my cholesterol?

Many people turn to probiotics hoping they'll improve both their gut health and even their skin. But what if your digestive symptoms (or that skin rash) actually get worse after starting them? In this episode, I explain what a reaction to probiotics means, why it shouldn't just be viewed as "die-off", and what it says about your gut health.We'll also explore the truth about probiotic side effects, why probiotics aren't the right fit for everyone, and how hidden gut imbalances can change the way your body responds. If you've ever wondered whether you should keep taking a probiotic that's making you feel worse, this episode will help you understand what's really going on and what steps to take next.⭐️Mentioned in This Episode:- See all the references

Looking for the run down on mast cells? We've got you covered. This week, we're joined by Dr. Sonal Choudhary as she walks us through Mast Cell Activation Syndrome. Listen in as she discusses the difficulty of diagnosis, what makes it controversial, and the latest science of MCAS. Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com. Sonal Choudhary, MD is a Board certified Dermatologist and fellowship trained Dermatopathologist, who joined the Department of Dermatology in 2016 upon completion of her Dermatopathology Fellowship at the University of Pittsburgh. Dr. Choudhary received her undergraduate degree and medical degree from Vardhman Mahavir Medical College in New Delhi India. She completed a post-doctoral research fellowship at the University of Miami, where she remained to complete her Preliminary Internship in Internal Medicine, as well as her Residency Program in Dermatology. Dr. Choudhary is also undergoing a fellowship in Integrative Dermatology which will conclude in February of 2024.   While she offers care for all dermatologic conditions, Her areas of clinical interest and research are atopic dermatitis, gut and skin microbiome, integrative dermatology, alternative therapies and approaches (herbs, supplements, functional medicine testing) to inflammatory skin diseases (Hidradenitis suppurativa, Acne, Psoriasis, hair loss), nutrition in cutaneous disease and dermatopathology. She is the director of the adult atopic dermatitis clinic, expert team member on hEDS/HSD group and member of the PCOS collaboration group at UPMC Magee. Given her areas of training, Dr. Choudhary offers a holistic and integrative approach for various skin conditions. She has extended collaborations with departments and specialties outside of Pitt Dermatology, such as Carnegie Mellon University Robotics Engineering department.   Dr. Choudhary is very well published and has authored articles published in high impact journal on a wide spectrum of dermatological disease states and management approaches. Her publications can be reviewed on pubmed. She is constantly involved in training the next generation of physicians from medical students, residents (dermatology and medicine), fellows and Physician assistants under her supervision. Professional memberships Member of Integrative Dermatology with Integrative Dermatology Certification Program/LearnSkin Fellow of Pittsburgh Academy of Dermatology Fellow of Pennsylvania Academy of Dermatology Fellow of American Academy of Dermatology Fellow of American Academy of Dermatopathology Education & Training MBBS, Vardhman Mahavir Medical College, Safdarjung Hospital, New Delhi, India Clinical Internship, Vardhman Mahavir Medical College, Safdarjung Hospital, New Delhi, India Post Doctoral Fellowship, University of Miami Miller School of Medicine Internship, University of Miami and Jackson Memorial Hospital Residency, Dermatology, University of Miami and Jackson Memorial Hospital Fellowship, Dermatopathology, University of Pittsburgh Medical Center Fellowship, Integrative Dermatology

Dr. Ted Lain sits down with board-certified pediatric dermatologist Dr. Nnenna Agim to discuss the toddler indication for roflumilast cream (Zoryve) and how non-steroidal topicals are changing the treatment landscape for atopic dermatitis, psoriasis, and seborrheic dermatitis in children. In this episode of the Science of Skin Podcast, Dr. Agim shares her real-world clinical experience using roflumilast cream 0.05% (ages 2-5) and 0.15% (ages 6+) as a steroid-sparing alternative for pediatric eczema, explaining why more families are requesting non-steroidal options from the start of treatment. The conversation covers: Why roflumilast (Zoryve) is safe to use on any body surface, including the face and skin folds Managing parent expectations and proper dosing to avoid overuse The importance of pairing roflumilast with ceramide-rich, fragrance-free moisturizers like CeraVe, La Roche-Posay, and Vaseline How roflumilast compares to crisaborole (Eucrisa) and topical corticosteroids in tolerability Treating psoriasis and seborrheic dermatitis in children with roflumilast foam and cream Skin barrier repair, ceramide production, and the role of the acid mantle in atopic dermatitis Caring for textured hair and scalp conditions in pediatric patients Real patient outcomes and quality-of-life improvements with Zoryve This episode is sponsored by Arcutis Biotherapeutics and is part of an ongoing series exploring roflumilast formulation science. Don't miss the related episode on roflumilast's formulation with Dr. Chris Bunick. Learn more about the Science of Skin Summit (Austin, TX) and the new Science of Skin Longevity Summit (Scottsdale, AZ, Feb 2027) at scienceofskinsummit.com.

Please visit answersincme.com/860/IME-020568-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Jeffrey M. Cohen, MD, MPH; Kristine Kucera, PA-C, MPAS, DHSc; and Lauren E. Miller, MPAS, PA-C. In this activity, experts in dermatology discuss the evolving role of next-generation TYK2 inhibitors in the treatment of patients with moderate to severe psoriasis. Upon completion of this activity, participants should be better able to: Explain the clinical rationale for TYK2 inhibitors in the management of patients with moderate to severe psoriasis; Differentiate the mechanism of action of TYK2 inhibition from other oral treatment options used for patients with moderate to severe psoriasis; and Apply available clinical evidence to identify patients with moderate to severe plaque psoriasis who may be appropriate candidates for TYK2 inhibitor therapy within current treatment paradigms. This activity is intended for US healthcare professionals only.

The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects. Features Dr. Jack Cush, Editor at RheumNow.com. Show Notes: - Breckenridge Pharmaceutical received FDA approval for their generic version of tofacitinib on 6/4/26. 5 mg and 10 mg tablets are now available in the U.S. market, for both adult and pediatric use. Tofacitinib Tablets are manufactured in Martorelles, Spain. https://t.co/oAh0KQSFgs - TB Infection or reactivation is Psoriasis or Psoriatic Arthritis pts taking IL-23 inhibitors is rare, rare. Literature review showed 34 studies of IL-23i in PsO had no new TB, but 1 case of LTBI reactivation. In 8 IL-23i PsA studies there were NO new TB or LTBI reactivations https://t.co/NFIap7DSOr   - BE BOLD: Bimekizumab Beats Risankizumab (LB0001) –H2H trial bimekizumab vs risankizumab in PsA for 24 weeks. At week 16; BKZ better than RZB,  p=0.0058). This advantage was maintained out to week 24 (55% vs 44%; p 0.0001). - RA-BRIDGE and RA-BRANCH: FDA mandated study of the risk of venous thromboembolic events (VTE) taking baricitinib (BARI) or TNF inhibitors. The incidence rate was 0.79/100 PY for BARI combined versus 0.51/100 PY for TNFi. The hazard ratio was 1.606 (95% CI 0.969–2.660), with the upper CI exceeding the pre-specified NI margin of 1.8.  Baricitinib (neither dose) was associated with a higher risk of MACE (HR 1.06), all-cause mortality (HR 0.97), arterial thromboembolism (HR 1.27), or opportunistic infections (HR 1.25).   - Probiotics in Psoriatic Arthritis. (POS0290)    66 PsA patients randomized to receive either placebo or probiotic containing lactobacillus and bifidobacterium strains for 12 weeks.  This trial proves no significant effect with oral probiotic supplementation in PsA.  - CLE and smoking. Smoking reduces efficacy of antimalarials & worsens dz activity & damage. Advocate for smoking cessation! @Rheumnow #EULAR2026 https://t.co/pEWLJAkBAJ - Risk of Psoriasis is increased 19% by long-term exposure to Particulate Matter (PM2.5 & PM10; adjHR 1.19), while short-term exposure increases risk of psoriasis exacerbation (adjusted OR 1.03). Stronger in younger, urban, lower SES, ever-smokers, & comorbid allergies https://t.co/pd6S13RG1B

The post From Endpoint to Exam Room: Understanding What Psoriasis Trials Really Tell Us appeared first on JDDonline - Journal of Drugs in Dermatology.

While the carnivore diet has helped some people improve gut, skin, and autoimmune symptoms, it's not always the success story social media makes it out to be. In this episode, you'll hear about unexpected problems that can arise and why some people experience worsening symptoms and rashes on the diet.If you've wondered about potential carnivore diet side effects, this conversation offers a perspective you may not have heard before. And learn how carnivore can impact your gut microbiome the longer you follow it and whether it will actually stop candida overgrowth.⭐️Mentioned in This Episode:- See all the references

Qué Temas Quieres Escuchar Toca y Hablemos. TE LEO.Muchas personas pasan años aplicando cremas, tomando medicamentos o probando distintos tratamientos para controlar problemas de piel que parecen no desaparecer. Al principio algunos funcionan, pero con el tiempo los síntomas regresan y comienza una búsqueda constante de nuevas soluciones.Cuando esto ocurre, pocas personas se preguntan qué está sucediendo realmente detrás del problema. ¿Es posible que el tratamiento se convierta en parte del problema? ¿Y qué consecuencias podría tener intentar controlar los síntomas durante años sin abordar la causa de fondo?En este episodio de “Cómo Curar”, junto a Michelle Peiret exploramos una realidad con la que muchas personas se sentirán identificadas: la frustración de probar una cosa tras otra sin encontrar respuestas duraderas. También hablamos sobre algunos tratamientos ampliamente utilizados y por qué, en ciertos casos, pueden terminar convirtiéndose en un círculo difícil de romper.En este episodio conversamos sobre:• El uso prolongado de esteroides y corticoides • Por qué algunos tratamientos dejan de funcionar con el tiempo • Problemas de piel que afectan la autoestima y la calidad de vida • Qué ocurre cuando el tratamiento de los síntomas deja de ser suficienteDisfruta de este episodio y muchos más en ComoCurar.com, en tu plataforma de podcast favorita o en YouTube, en el canal Cocó March N.M.D.#DraCocoMarch #TipsCocoMarch #CocoMarch #SaludDeLaPiel #Psoriasis #Rosacea #Melasma #Acne #Dermatitis #Corticoides #Esteroides #InflamacionCronica #PielSana #CuidadoDeLaPiel #SistemaInmune #EnfermedadesDeLaPiel #Episodio163 #Temporada4 #ComoCurarConsigue mis fórmulas en USA y México: https://store.dracocomarch.com/es/Consigue mis fórmulas en Europa:https://vitatiendaeuropa.com/es/Visita mi Podcast:https://comocurar.com/Sígueme en redes:https://www.facebook.com/CocoMarchNMDhttps://www.instagram.com/cocomarch.nmd/https://www.youtube.com/@CocoMarchNMDhttps://www.tiktok.com/@coco.march.nmd Aprende de mi blog:https://blog.dracocomarch.com

In this episode of the DIGA Podcast, we continue our Dermatology Crash Course mini series with a high-yield discussion on Psoriasis led by Dr. Nikki Trupiano. We hope you enjoy!About the Dermatology Crash Course Series The Dermatology Crash Course is a DIGA Podcast mini-series focused on delivering short, high-yield episodes that cover foundational dermatology topics. Each episode features a dermatologist sharing practical insights to help learners develop confidence in recognizing and managing common skin conditions.Learn More:Educational links: AAD Educational ModulesConnect with Dr. Trupiano:Instagram: @nikki_trupianoEmail: nikki.trupiano@northwestern.edu---DIGA Instagram: @derminterestToday's Host, George: @georgepapadeas---For questions, comments, or future episode suggestions, please reach out to us via email at derminterestpod@gmail.com ---District Four by Kevin MacLeodLink:https://incompetech.filmmusic.io/song/3662-district-fourLicense:https://filmmusic.io/standard-license---

Are peptides safe? And is it possible that with their growing interest for everything from injury recovery and exercise performance to weight management and healthy aging, it's no surprise that important drawbacks are overlooked? Like could peptides fuel cancer growth?That's why it may be increasingly risky to overlook key factors like lab testing, inflammation, and individual health history when deciding if peptides are right for you. My guest, Dr. Elena Zinkov, is a naturopathic medical doctor and entrepreneur who specializes in hormone optimization, longevity, and regenerative medicine. With a science-backed approach to healthspan, she is passionate about helping women access personalized solutions that support vitality and well-being at every stage of life.⭐️Mentioned in This Episode:- See all the references

2026 EULAR Preview Imaging in Subclinical Psoriatic Arthritis Dietary Interventions in PsA This Is a Woman's World: Women's Health in Rheumatic Disease Impact of Synovial Biopsy-Driven Therapeutic Stratification in PsA Can We Stop PsA Before it Starts? BE BOLD: Going Where No PsA Trial Has Gone Before BMI Outranks Treatment in PsA Outcomes? Debate: Combination Therapies for Inflammatory Arthritis? Combination Biologics in PsA: MRI Findings from AFFINITY Combination Therapy in SpA The Case for Dual Pathway Blockade in Refractory PsA The AFFINITY Study: Combination Treatment in PsA PsA Potpourri: Probiotics & Head-to-Head Data Transition from Psoriasis to Psoriatic Arthritis MACE and Safety Profile of bDMARDs/JAKis in axSpA and PsA Guselkumab Delivers Across the PsA Disease Spectrum: APEX Trial  

Think you'd know if you had parasites? Many people assume parasite symptoms are obvious, like severe diarrhea or illness after international travel. But as this episode reveals, parasites can show up in unexpected ways, including constipation, chronic skin rashes, and symptoms unrelated to digestion.Join me to unpack three common parasite myths that you cannot trust. And believing in them keeps you from healing while distracting you from important clues in your own health journey. You'll learn why you can't trust negative test results, how past travel can be a major clue, and commonly missed parasite signs that many functional practitioners blame on other problems.⭐️Mentioned in This Episode:- Want personalized help to fix your skin (especially if you suspect parasites)? Get started here with Jennifer's virtual clinic

Debate: Combination Therapies for Inflammatory Arthritis? Combination Biologics in PsA: MRI Findings from AFFINITY Combination Therapy in SpA Digital Patient Education in RA The Case for Dual Pathway Blockade in Refractory PsA The AFFINITY Study: Combination Treatment in PsA PsA Potpourri: Probiotics & Head-to-Head Data Transition from Psoriasis to Psoriatic Arthritis  

Description:  How do GLP-1 receptor agonists or GIP agonists work and what is the impact for my psoriatic disease? Hear dermatologist Dr. Ronald Prussick and cardio-immunologist Dr. Brittany Weber answer such questions and more.           Join host Archie Franklin as he takes a deep dive into the use of GLP-1 receptor agonists and GIP agonists and the convergence of systemic inflammation related to psoriatic disease with renowned dermatologist and Vice Chair of the NPF Medical Board, Dr. Ronald Prussick from Washington Dermatology Center in Rockville and Frederick, MD, and, cardio-immunologist Dr. Brittany Weber, Director of the Cardio-Rheumatology/ Cardio-Dermatology Program at the University of Texas Southwestern. Learn more about the use of incretin hormones, the impact of weight management on psoriatic disease, metabolic and cardiovascular risk, as well as results from the TOGETHER-Pso and TOGETHER-PsA clinical trials.  This episode addresses the actions of incretin hormones (GLP-1 receptor agonist and GIP agonist) and how such use may be beneficial in the management of inflammation related to psoriasis and psoriatic arthritis.  Thank you to Lilly for their support of this program activity.  Timestamps: (0:00)  Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. Ronald Prussick and cardio-immunologist Dr. Brittany Weber.  (1:35)  What are incretin hormones and how GLP-1 or GIP receptor agonists (RA) inhibit appetite to initiate weight loss. (3:29)  Why GLP-1 RAs are of interest in the management of psoriasis and psoriatic arthritis. (5:23)  The metabolic, cardiovascular, and psoriatic disease convergence. (7:19)  Will reduction of inflammation impact cardiovascular risk? (10:59) Treatment challenges associated with having psoriatic disease and being overweight or obese. (13:45)  Key points around the use of GLP-1 receptor agonists when managing psoriasis and psoriatic arthritis. (17:06)  Results of the TOGETHER-PsO and TOGETHER-PsA phase 3 clinical trials combining use of an IL-17 inhibitor and a GIP and GLP-1                receptor agonist therapy. (19:07)  Having the conversation of adding a GLP-1 RA medication to a treatment regimen. (22:40)  The paradigm shift of GLP-1 receptor agonists and the impact they can have on shared inflammatory pathways. Key Takeaways: ·       Glucagon-like peptide-1 (GLP-1) receptor agonists and glucose-dependent insulinotropic polypeptide (GIP) agonists are two incretin hormones that assist in managing excess body weight -- which as a result can be helpful in managing inflammation in the body.   ·       Psoriasis isn't just a skin and joint disease. It's a complex network of systemic inflammation with shared inflammatory pathways that worsens with increased weight impacting the severity of the disease, and accelerates the risk of metabolic dysfunction, and cardiovascular disease.   ·       The best outcomes occur as a result of multidisciplinary collaboration to address the impact of excess weight and systemic inflammation. If you are struggling to lose weight with diet and exercise, speak with your medical team about your options including the use of GLP-1 or GIP agonists.   Guest Bios: Renowned dermatologist Ronald Prussick, M.D., Medical Director of the Washington Dermatology Center in Rockville and Fredrick, Maryland, specializes in the treatment of psoriasis along with other diseases of the skin, hair, and nails. Dr. Prussick is also a Clinical Associate Professor in Dermatology at George Washington University in Washington, D.C.. Dr. Prussick has a research interest in the impact of diet on psoriatic disease and metabolic health, first becoming interested after being involved in Dr. Joel Gelfand and Dr. Nehal Mehta's work in vascular inflammation trials using FDG-PET/CT scans to view systemic and cardiovascular inflammation associated with psoriatic disease. Dr. Prussick has since participated in the development of the 2018 Dietary Recommendations for Adults with Psoriasis or Psoriatic Arthritis and more recently the position statement "GLP-1 Receptor Agonists in Psoriasis: A Primer from the National Psoriasis Foundation Medical Board". Dr. Prussick is Vice Chair of the NPF Medical Board which provides clinical direction, treatment guidance, and education oversight to the organization and its Executive leaders.  Brittany Weber, M.D., Ph.D. is a cardio-immunologist who is the Director of the Cardio-Rheumatology/ Cardio-Dermatology Program at the University of Texas Southwestern. She is also a member of the Division of Cardiology, a clinical investigator, and imaging specialist. Dr. Weber's research integrates advanced imaging, molecular biology, clinical trials, and population health to understand how systemic inflammation and immune deregulation drives cardiovascular dysfunction. Prior to joining UT Southwestern in 2025, Dr. Weber served on the faculty at Harvard Medical School and was the Director of the Cardio-Rheumatology Clinic at Brigham and Women's Hospital, a nationally recognized clinic addressing inflammation-related heart disease through collaborative, patient centered care. Dr. Weber is also an author on the position statement "GLP-1 Receptor Agonists in Psoriasis: A Primer from the National Psoriasis Foundation Medical Board". Resources: "The Metabolic Collison and How You Can Take Control with Psoriatic Disease" podcast episode with dermatologist Dr. Ronald Prussick and registered dietitian Danielle Cahalan   "NPF Medical Board Issues GLP-1 Primer for Dermatologists" Press Release "Finding My Path to Managing Psoriatic Disease and Excess Weight" podcast episode featuring dermatologist Dr. Erin Boh, patient advocate Brian Lehrschal, and moderator Jennifer Bomberger. 

Michele Scarlet sits down with RN, Nurse Practitioner, and Functional Diagnostic Nutrition Practitioner Connie Wade for an honest conversation about what 25 years inside the emergency room taught her about the limits of conventional medicine, why her own doctor told her she was not "sick enough" to treat, and how she finally healed the symptoms she had been "swiping away" for years. In this powerful Health Detective Podcast episode, Connie shares her personal journey through psoriasis, debilitating joint pain at 48, chronic reflux, daily ibuprofen use, estrogen dominance, heavy painful periods, more than 20 years of night shift, H. pylori, an overwhelmed liver and gallbladder, food sensitivities to her favorite foods, and a depleted gut microbiome. Together, Michele and Connie unpack how functional lab testing gave Connie the vindication she had been looking for, why she healed in three months once she addressed the root causes, and why she chose to keep working in the ER while building her functional health practice on the side. This episode dives deep into: Why her doctor said "she wasn't sick enough" and sent her home with ibuprofen The functional labs that finally explained her symptoms after years of being dismissed How 20 plus years of night shift flatlined her cortisol and disrupted her hormones H. pylori, food sensitivities, and the gut findings that changed everything Why psoriasis, joint pain, and heavy periods are not just "normal aging" The reframe that helped Connie cut gluten, sugar, and dairy without feeling deprived Why so many nurses are leaving bedside nursing and the third option most do not consider How to build a functional nursing side practice without leaving your license or your job Why going all in or all out of conventional medicine limits your reach as a clinician The four simple daily practices Connie recommends to every patient How to ask your family for support when you start your healing journey Michele and Connie also discuss why the body is constantly trying to send messages, why most of us swipe them away for years, and why functional lab testing catches dysfunction long before conventional labs ever turn "abnormal." If you are a woman struggling with joint pain, psoriasis, hormone imbalance, or symptoms your doctor keeps dismissing, or you are a nurse, NP, or clinician quietly exploring functional medicine as a career path, this episode will change how you view your body and what is possible.

This podcast episode features a powerful role reversal as host Sarah Dawkins, author of Heal Yourself and a registered nurse, steps into the interviewee seat. Guest host Bethany Shipley explores Sarah's journey from the front lines of cardiothoracic nursing to becoming a global advocate for natural self-healing.Episode OverviewSarah spent years on the front lines of surgery, surrounded by the best medicine money could buy. But while she was saving lives, her own body was falling apart. Psoriasis, depression, PTSD and chronic pain.Sarah didn't just find a new prescription, she found a new path. Meet Sarah Dawkins: The nurse who stopped following orders, defied her training and healed herself. We're diving into the "crisis of conscience" that changed everything.Why Listen?If you have ever felt "sick and tired of being sick and tired," this episode offers a roadmap of hope. Sarah's story proves that healing isn't just for a "special" few, it is a possibility for anyone willing to listen to their body and step outside their comfort zone.Key Topics & Timestamps02:10 The specific 2005 encounter in a Florida hospital that challenged Sarah's beliefs about pharmaceuticals.02:54 Navigating a deep depression and the "crisis of conscience" while working in cardiothoracic surgery.03:53 Why Sarah hid her book for 5 years and how she eventually gathered 74 contributors to provide "social proof" that healing happens.07:01 The moment Sarah was reported to the nursing board for sharing her natural thyroid healing journey.09:42 A list of the physical conditions Sarah healed, from psoriasis and acid reflux to chronic joint pain and PTSD.12:06 An honest look at bulimia, emotional eating, and how "disgust" became a catalyst for change.18:05 Sarah's simple rule: "If I don't buy it, I can't eat it."20:34 The "Single-Ingredient Food" strategy for feeding picky kids and busy families.24:29 Why Sarah chose to bypass traditional publishing to get the message to the public faster.28:02 Understanding the metaphysical link between "frozen shoulders" and carrying the weight of the world.29:51 How spinal pain often correlates to feelings of financial or personal insecurity.31:41 Using short meditations to stop "checking out" via food, alcohol, or scrolling.33:45 Why we are afraid to trust our own feelings and how to stop seeking external approval.Bethany's Bio Bethany Shipley is a writer, speaker, and philosophical guide for people who are ready to live a life that is true to them.Her work centers around a powerful idea: Being influences Doing. When you understand who you are at your core and have the courage to live from that place, your actions naturally align and your life begins to reflect something deeply authentic.Bethany is known for blending grounded insight with spiritual depth, helping people reconnect to their instinct, expression, and internal compass. She moves beyond hype and surface-level encouragement, guiding people into a lived experience of alignment.Through her podcast, Market Your Personal Brand and upcoming book, she empowers and inspires people to live an authentic life.Connect with Bethany https://www.bethanyshipley.com/Who am I?Sarah Dawkins is a passionate Holistic Health and Healing Coach, international speaker and author of Heal Yourself. She's also a multi-award-winning entrepreneur and the award-winning host of the uplifting podcast Mind Body Medicine for Self Healers with Sarah Dawkins.With over 20 years' experience as a Registered Nurse, Sarah combines her deep understanding of conventional medicine with her own powerful self-healing journey to create a truly integrative approach. Having overcome multiple chronic health challenges herself, she now supports others in uncovering and addressing the root causes of their symptoms, helping them restore balance, reclaim their energy and create lasting, vibrant wellness.www.sarahdawkins.com

Dr. Marty Makary out as FDA Commissioner—was he the victim of a BigPharma purge? Are “liquid biopsies” useful for predicting recurrences, as well as guiding therapy, for cancer? Nighttime smartphone by adolescents surges, eroding kids' sleep needs; Persistent itch may require an “all of the above” approach to break its vicious cycle—could topical vitamin B12 provide an answer? Study critiques research methods that fast-tracked new Alzheimer's drugs.

If you're struggling with dyshidrotic eczema and stuck in the cycle of restrictive diets, expensive creams, and an endless search for answers, this episode offers a fresh perspective. Discover why hand eczema is connected to deeper issues like gut health imbalances, nutrient deficiencies, and immune system dysfunction, rather than just blaming it all on food sensitivities.In this conversation, I explore how common approaches to hand eczema can actually make your rash worse, along with practical insights into what steps support healing. If you've had enough of cracked, itchy, painful, or constantly flaring hands, this episode is for you!⭐️Mentioned in This Episode:- See all the references

Description: "When joint pain is present, the diagnosis of psoriatic arthritis needs to be made as soon as possible, ideally within six months to limit joint inflammation" Dr. Vinod Chandran mentions as he discusses efforts to identify a diagnostic test for those at risk of developing psoriatic arthritis.          Join host Jeff Brown as he speaks with leading rheumatologist and clinician scientist Dr. Vinod Chandran, Director of the Gladman Krembil Psoriatic Arthritis Program, Schroeder Arthritis Institute, University Health Network and the Departments of Medicine, Laboratory Medicine and Pathobiology, and the Institute of Medical Science at the University of Toronto to learn more about the progress and promising results towards developing a psoriatic arthritis diagnostic test through multi-omic assays and identifying the distinct differences between psoriasis and psoriatic arthritis.  This episode provides an update on the progress to date of the NPF PsA Diagnostic Test grant initiative which has shown promising results with a potential test entering prospective study in multiple sites soon.   Thank you to Johnson and Johnson for their support of this program activity. Timestamps: (0:00)          Intro to Psoriasis Uncovered & guest welcome rheumatologist Dr. Vinod Chandran.    (0:52)          It is challenging to diagnose psoriatic arthritis with many factors leading to a delay in diagnosis. (4:56)          The start of Dr. Chandran's involvement with the PsA Diagnostic Test Grant project.   (7:55)          The different types of omics and the definition of multi-omic. (9:57)          How the multi-omic approach is used to find biomarkers relative to a specific disease pattern. (11:08)        Development of a predictive or prevention-based test using gene expression.      (13:46)        First year results identify 200 markers across different omic approaches that distinguish psoriatic arthritis from psoriasis.    (14:58)        The significance of MRNA vs mIcroRNA's use in development of a diagnostic test and how critical that is to dissemination of a                     potential test. (17:08)        Identifying the skin-joint axis in relation to different types of arthritis. (20:20)        Next steps to moving the diagnostic test research forward as a prospective study in multiple sites and the cost effectiveness of                  delivering the test.   (23:13)        If you have psoriasis, musculoskeletal, back, and joint pain think of psoriatic arthritis and be diagnosed early to maintain a good                 quality of life. Key Takeaways: ·       Given challenges associated with diagnosing psoriatic arthritis and the impact on quality of life, in 2019 NPF launched the PsA Diagnostic Test Grant project with the goal of developing an early stage test that would identify and diagnose those with psoriatic arthritis before debilitating  joint damage begins.   ·       Progress towards a PsA Diagnostic Test includes the study of multi-omic data sets where 200 distinct biomarkers have been identified leading to a greater understanding of the different pathways between psoriatic arthritis, psoriasis, and the skin joint axis.  ·       A potential diagnostic test is now moving towards the prospective study phase. Until the test is available and if joint pain is present and you have psoriasis, ask your health care provider if it could be psoriatic arthritis and treat appropriately.  Guest Bio: Vinod Chandran, MBBS, MD, DM, PhD is a rheumatologist, clinician scientist, and Director of the Gladman Krembil Psoriatic Arthritis Program, Schroeder Arthritis Institute, University Health Network and the Departments of Medicine, Laboratory Medicine and Pathobiology, and the Institute of Medical Science at the University of Toronto where he is also a Professor of Medicine. His specialties include internal medicine, immunology, rheumatology, and genetic epidemiology. His research focus is on the development of biomarker-based strategies to improve early diagnosis and prognosis of psoriasis and psoriatic arthritis, identification of new treatment targets especially for those who do not respond to current therapies, and strategies to reduce the impact of disease. Dr. Chandran is a Co-Vice President of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis or GRAPPA. He is an active collaborator in a multi-center research consortia such as the International Psoriasis and Arthritis Research Team and the Spondyloarthritis Research Consortium of Canada. Dr. Chandran is the recipient of research funding from the National Psoriasis Foundation for his work in identifying a "Multi-omic Diagnostic Test for PsA in Psoriasis Patients". Resources: "Understanding the NPF Psoriatic Arthritis Diagnostic Test Grant Outcomes" Advance Online. February 18, 2026.  "Managing Chronic Pain with Psoriatic Arthritis" Psoriasis Uncovered podcast episode with physiatrist Dr. Erin Maslowski, LB Herbert who lives with psoriatic disease, and moderator Susan McClelland-Tobert, a retired pediatric cardiologist who also lives with psoriatic disease. Glossary of terms: mRNA: Messenger RNA carries protein information or instructions from the DNA in a cell's nucleus to the cell's interior where the sequence is read and translated into corresponding amino acids for growing protein chains. Micro-RNA (miRNA):  Micro-RNA act as the regulator. They are short and bind to specific target mRNA's to degrade or inhibit production of protein. 

What comes first: the obesity or the skin inflammation?  We've got just the expert to help us find out. This week, we're joined by Dr. Ganary Dabiri as she walks us through the relationship of obesity and the skin. Listen in as she discusses skin diseases, how to use "people first" language, and the clinical possibilities of GLP-1 medications. Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com. Dr. Ganary Dabiri is double board-certified in Dermatology and in Obesity Medicine. She earned her graduate and medical degree from Albany Medical College. She completed her Dermatology Residency at Roger Williams Medical Center. In 2024 she completed her requirements and obtained board certification in Obesity Medicine. Dr. Dabiri is an adjunct assistant professor at Albany Medical College. She works in private practice in Milford, Massachusetts. In 2024, Dr. Dabiri started the first Skin Inflammation and Obesity Medicine Specialty Clinic in Massachusetts. This comprehensive clinic focuses on and treats patients not only for their chronic inflammatory dermatologic condition such as Psoriasis, Hidradenitis Suppurativa, PCOS, and Atopic Dermatitis but treats their concurrent obesity. Since the inception of this clinic, she has helped numerous patients achieve clearer skin, improve their joint health, but equally if not more importantly - improve their overall health.

Could GLP-1 medications be the missing piece in treating inflammatory skin disease? In this episode of Science is Skin, Dr. Ted Lain sits down with Dr. Lindsey Bordone — former Columbia University associate professor of dermatology, now in private practice at Bordone Dermatology in Scottsdale, Arizona — for a deep dive into metabolic disease and the skin. Dr. Bordone was among the first dermatologists to prescribe GLP-1 agonists for her patients, and in this conversation she explains exactly why. From the link between hyperinsulinemia and chronic inflammation to the visible skin signs of insulin resistance — skin tags, acanthosis nigricans, forearm hair loss — she makes the case that dermatologists are uniquely positioned to catch metabolic disease before any other specialty. Dr. Bordone walks through how she uses tirzepatide (Mounjaro/Zepbound), semaglutide (Ozempic/Wegovy), and the emerging triple-G drug retatrutide, including her lab protocols, dosing philosophy, how to manage GI side effects, and the surprising interaction between GLP-1s and estrogen therapy. In this episode: Why high BMI reduces biologic efficacy in psoriasis patients How to check fasting insulin (HOMA-IR) and why most physicians aren't doing it Skin signs of insulin resistance: skin tags, forearm hair loss, and neck skin thickening Tirzepatide vs. semaglutide vs. retatrutide — how to choose and when Retatrutide's remarkable 93% fatty liver clearance rate in clinical trials The truth about sarcopenia and muscle loss on GLP-1 medications Dosing protocols, side effect management, and when NOT to escalate quickly Protein intake recommendations during active weight loss Estrogen and GLP-1 synergy — what dermatologists need to know Lab work to run before and during GLP-1 therapy How to build an insurance case for continued medication coverage Resources mentioned: HOMA-IR fasting insulin/glucose testing AAD resources on metabolic dermatology Bordone Dermatology — Scottsdale, Arizona Enjoyed this episode? Share it with a colleague and leave us a five-star review. Subscribe so you never miss an episode of Science is Skin. To watch this and other episodes, be sure to check out our YouTube page DISCLAIMER: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.See omnystudio.com/listener for privacy information.

Description: "What is metabolic disease and why do I have it on top of psoriatic disease?" Hear dermatologist Dr. Ronald Prussick and registered dietitian Danielle Cahalan explore this collision of diseases and how you can take control to help reduce the impact of inflammation.           Join host Corinne Rutkowski as she discusses why metabolic disease occurs with psoriasis and psoriatic arthritis and what can be done to improve overall health with dermatologist and Vice Chair of the NPF Medical Board, Dr. Ronald Prussick from Washington Dermatology Center in Rockville and Frederick, MD, and Danielle Cahalan, a registered dietitian and coach with All Access Dietitians. Listen as they also discuss the four pillars of health, the latest evidence around use of the Mediterranean Diet with psoriatic disease, key nutrients that impact overall health from omega 3's, polyphenols, and fiber, to making small sustainable changes.  This episode offers information to help explain the connection between metabolic and psoriatic disease and what can be done to decrease health risks associated with both diseases through sustainable changes. Timestamps: (0:00)  Intro to Psoriasis Uncovered & guest welcome dermatologist Dr. Ronald Prussick and registered dietitiand and coach                  Danielle Cahalan.                                                                                              (1:27)  Definition of metabolic disease and why the risk is higher among those with psoriasis or psoriatic arthritis. (3:11)  How this bi-directional relationship impacts the management of psoriasis and psoriatic arthritis. (6:54)  The four pillars of health that can be used to reduce the risk of metabolic disease.   (11:17) Does an anti-inflammatory diet exist? (13:46) What is the Mediterranean diet and the foods that are typically included. (16:32) The impact of the Mediterranean diet on systemic inflammation, metabolic health, and severity of psoriatic disease. (21:03) The three types of healthy fats – what they are, how they work, and where to find them. (24:50) The high polyphenol Mediterranean diet from what that means to choosing nutrient dense, colorful foods. (28:04) The koebnerization of the gut microbiome and the impact of the Mediterranean diet and high fiber. (30:59) The DASH diet in combination with the Mediterranean diet lowers oxidative stress and inflammation. (33:14) Sustainability of the Mediterranean diet and flexing behavioral health changes long term.  (37:43) Start with small habit changes and then build from there to have an impact on your metabolic health.  Key Takeaways: ·       Research shows a bi-directional relationship between psoriasis and excess body weight leading to increasing severity of disease, decrease in treatment effectiveness, and the development of metabolic syndrome, a group of conditions which together raise the risk of coronary heart disease, stroke, and diabetes. ·       What you choose to eat can make an impact in managing inflammatory markers, metabolic health to increase insulin sensitivity, decrease high blood pressure, improve lipids and the gut microbiome, as well as support neuro protection and decrease cognitive decline. ·       Create small sustainable habits that make positive changes to your immune system and gradually work towards building a foundation that benefits your overall health. Guest Bios: Renowned dermatologist Ronald Prussick, M.D. is the Medical Director of the Washington Dermatology Center in Rockville and Fredrick, Maryland where he specializes in the treatment of psoriasis along with other diseases of the skin, hair, and nails with the latest technology and products. Dr. Prussick is also a Clinical Associate Professor in Dermatology at George Washington University in Washington, D.C.. Dr. Prussick has a research interest in the impact of diet on psoriatic disease and metabolic health. He first became interested after being involved in Dr. Joel Gelfand and Dr. Nehal Mehta's work in vascular inflammation trials using FDG-PET?CT scans to view systemic and cardiovascular inflammation associated with psoriatic disease. Dr. Prussick also participated in the development of the 2018 Dietary Recommendations for Adults with Psoriasis or Psoriatic Arthritis from the Medical Board of the NPF, which offered a review of studies addressing the impact of dietary interventions in people with psoriasis and psoriatic arthritis. Dr. Prussick is Vice Chair of the NPF Medical Board which provides clinical direction, treatment guidance, and provides education oversight to the organization and its Executive leaders. Danielle Cahalan, MS, RDN is a licensed and registered dietitian and coach with All Access Dietitians which offers virtual nutrition support services in AZ, CA, CO, CT, FL, IL, IN, MA, MO, MT, NJ, NY, NC, OR, PA, SC, TX, VA, WA, WI, and WY. All Access Dietitians infuses the science of motivation, habit formation, and sustainable behavior change into every session that addresses weight management and metabolic health, to women's health and digestive support. Danielle's primary focus during sessions is to help her clients find that intersection between enjoyment and satisfaction with their food choices that also support their health through sustenance. It's about finding that balance between feeling empowered, energized, and confident in the ability to make decisions that impact health, wellness, and longevity. Resources: "Mediterranean Diet Pyramid: Guidelines for Healthy Eating" © 2009 Oldways Preservation and Exchange Trust www.oldwayspt.org and UCSF Weill Institute for Neurosciences Memory and Aging Center. DASH Eating Plan (Dietary Approaches to Stop Hypertension). February 25, 2026. NIH (National Heart, Lung, and Blood Institute)  Mediterranean Diet and Patients With Psoriasis: The MEDIPSO Randomized Clinical Trial. AMA Dermatology . Dec. 1, 2025  The Mediterranean Diet as a Potential Solution to the Gut Microbiome Dysbiosis in Psoriasis Patients Journal of Psoriasis and Psoriatic Arthritis 2024 Jan 9.

La psoriasis pediátrica es una condición que no sólo afecta la piel, sino también se asocia a comorbilidades significativas y a una disminución de la calidad de vida de los niños y sus familias. En este episodio profundizamos en el tema con una experta en la materia, desde cómo se manifiesta la psoriasis pediátrica, sus potenciales causas y alternativas de tratamientos. Nos acompaña la Dra. Paula Luna desde Buenos Aires, Argentina. La Dra. Luna es dermatóloga y dermatóloga pediatra en el Hospital Alemán en Buenos Aires, Argentina, donde también dirige la beca en psoriasis y otras enfermedades inflamatorias. Se desempeña como secretaria general de la Sociedad Argentina de Psoriasis y de la Sociedad de Dermatología Pediátrica para América Latina. Después de completar su residencia en dermatología y de ejercer como jefa de residentes, la Dra. Luna realizó la subespecialidad de tres años en dermatología pediátrica en el Hospital Ramos Mejía de Buenos Aires. Instagram: @‌drapauluna ¿Tienes algún comentario sobre este episodio o sugerencias de temas para un futuro podcast?  Escríbenos a pediatrasenlinea@childrenscolorado.org.

The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects.  Features Dr. Jack Cush, Editor at RheumNow.com. Show Notes: Chinese target emulation trial of MDA-5+, dermatomyositis w/ ILD. 106 Rx w/ UPA & 328 w/ TOFA. 6-month lung transplantation-free survival 72% vs 67% (UPA v TOFA). UPA non-inferior to TOFA in MDA5+DM-ILD https://t.co/BBAfbM06AM In 2025 DTC TV ad spending by top 10 incr to $2.67 billion (up from $2.1 B). Rheum Drugs in top 3: 1. Skyrizi $440 million 2. Tremfya $431 M 3. Rinvoq $376 M https://t.co/EsWgUqUy9Z 2. Dermatology Salaries 2025 – Dermatology is top 10 at $448K according to Medscape; expected to go down -1% in 2026; derms made up 2% of survey group 37K MDs 3. Itch is common in Scleroderma (SSc) and not related to Dz duration. Study of 2173 Pts (~20K itch assessments), 87 F; mean age 55 yrs; 40% w/ diffuse SSc. Itch (moderate 4/10) seen in ~35% at all times https://t.co/QnT8d0xA5Z 4. Asia-Pacific Lupus study of Mucocutaneous activity (MC-A) in 4102 SLE pts. 36% had MC-A (rash 1055; alopecia 731; m ulcers 352); 15% persistently. MC-A assoc w/ W, smoking, +serologies, vasculitis, myositis, serositis, nephritis, NP-SLE https://buff.ly/D5fXJdY 5. Predictors of Calcinosis Cutis in Systemic Sclerosis   6. AFFINITY Study - Combination Biologic Therapy in PsA A pilot trial assessed the efficacy and safety of the guselkumab+golimumab (COMBO) combination versus GUS monotherapy in active PsA (failing a prior tumor necrosis factor inhibitor (TNFi-IR) and showed superiority in ACR 50 https://t.co/f2CB8FnZMB 7. AAD 2026 Annual Mtg presents new data on another TYK2 inhibitor. In 2 phase 3 RCTs (ONWARD1 ONWARD2) envudeucitinib was superior to placebo & apremilast in 1700 plaque psoriasis pts https://t.co/DPlzDw5m7N 8. Among 1074 #PsA tested annually, RF positivity was found in 16.1% overall (5.1% RF+ at baseline). RF+ rediced odds of MDA (OR 0.53) w/ incr risk of bDMARD discontinuation (OR 2.65) https://buff.ly/BsM7NKQ 9. The National Psoriasis Foundation Primer on GLP-1 Receptor Agonists in Psoriasis - Review 10. Ixekizumab With Tirzepatide Efficacy in Obese Psoriatic Arthritis 11. Brepocitinib in Dermatomyositis

Bloating after meals, constipation, or sudden urgency to run to the bathroom are often brushed off as normal, but they can be signs of irritable bowel syndrome. In this episode, we unpack why IBS is often treated as a label to justify medications rather than a sign pointing you to issues brewing under the surface.Joining me today is Dr. Izabella Wentz, an integrative pharmacist, thyroid expert, and bestselling author known for helping people uncover the root causes of chronic health issues.So if you have tried elimination diets, probiotics, or leaky gut supplements without lasting relief, this conversation is for you!⭐️Mentioned in This Episode:- My FAV gut support

If there are five people in a room with eczema, they're probably all dealing with it for completely different reasons.And that's something we don't talk about enough.Eczema, acne, psoriasis… these are rarely just skin issues. They're often a reflection of what's happening inside the body, particularly in the gut.So instead of just asking what to put on your skin, this episode is about asking a better question. What's actually driving this underneath?My guest today is Farzanah Nasser, a registered nutritionist and certified functional medicine practitioner specialising in gut health, immune health and chronic skin conditions.She works with people every day, dealing with long-standing skin issues using a practical, gut-first approach.She's also the author of “The Everyday High-Fibre Plan”, full of simple, gut-friendly recipes… including those cookies on the table if you're watching on YouTube

It probably doesn't surprise you that HS (hidradenitis suppurativa) is much more than just a skin condition. There is an increasing body of research showing how HS is linked to immune dysfunction, gut health, liver problems, hormone imbalances, and so much more that often goes overlooked in conventional medical care.In this episode, I'm diving into the links between Hidradenitis suppurativa and autoimmune disease, liver health, thyroid dysfunction, and gut health, so you can spot red flags and get help sooner!⭐️Mentioned in This Episode:- See all the references

Dermoscopy master class - with Dr. Michael Christopher! [⁠article⁠]The plumage sign in dermoscopy: pigmented SCCis [⁠article⁠] Highlights from the AAD -Icotrokinra for psoriasis [⁠article⁠] Learn more from Dr. Christopher! Instagram: @michael_christopher_mdCheck out Luke's Urticaria CME experience! ⁠aaaaicsu.gathered.com/invite/KQe1wPZbJY⁠ Learn moreabout the U of U Dermatology ECHO model! ⁠physicians.utah.edu/echo/dermatology-primarycare⁠ Want to donate to the cause? Do so here!Donate to the podcast: ⁠⁠uofuhealth.org/dermasphere⁠⁠Check out our video content on YouTube:⁠⁠www.youtube.com/@dermaspherepodcast⁠⁠and VuMedi!: ⁠⁠www.vumedi.com/channel/dermasphere/⁠⁠The University of Utah's DermatologyECHO: ⁠⁠⁠physicians.utah.edu/echo/dermatology-primarycare⁠⁠ -Connect with us!- Web: ⁠⁠⁠dermaspherepodcast.com/⁠⁠⁠ - Twitter: @⁠DermaspherePC⁠- Instagram: dermaspherepodcast- Facebook: ⁠⁠www.facebook.com/DermaspherePodcast/⁠⁠- Check out Luke and Michelle's other podcast,SkinCast! ⁠⁠⁠healthcare.utah.edu/dermatology/skincast/⁠⁠⁠ Luke and Michelle report no significant conflicts of interest… BUT check out our friends at:- ⁠Kikoxp.com ⁠(a social platform for doctors to share knowledge)- ⁠⁠⁠www.levelex.com/games/top-derm⁠⁠⁠ (A free dermatology game to learn more dermatology!

Dermoscopy master class - with Dr. Michael Christopher! [article]The plumage sign in dermoscopy: pigmented SCCis [article] Highlights from the AAD -Icotrokinra for psoriasis [article] Learn more from Dr. Christopher! Instagram: @michael_christopher_mdCheck out Luke's Urticaria CME experience! aaaaicsu.gathered.com/invite/KQe1wPZbJY Learn moreabout the U of U Dermatology ECHO model! physicians.utah.edu/echo/dermatology-primarycare Want to donate to the cause? Do so here!Donate to the podcast: ⁠uofuhealth.org/dermasphere⁠Check out our video content on YouTube:⁠www.youtube.com/@dermaspherepodcast⁠and VuMedi!: ⁠www.vumedi.com/channel/dermasphere/⁠The University of Utah's DermatologyECHO: ⁠⁠physicians.utah.edu/echo/dermatology-primarycare⁠ -Connect with us!- Web: ⁠⁠dermaspherepodcast.com/⁠⁠ - Twitter: @⁠DermaspherePC⁠- Instagram: dermaspherepodcast- Facebook: ⁠www.facebook.com/DermaspherePodcast/⁠- Check out Luke and Michelle's other podcast,SkinCast! ⁠⁠healthcare.utah.edu/dermatology/skincast/⁠⁠ Luke and Michelle report no significant conflicts of interest… BUT check out our friends at:- ⁠Kikoxp.com ⁠(a social platform for doctors to share knowledge)- ⁠⁠www.levelex.com/games/top-derm⁠⁠ (A free dermatology game to learn more dermatology!